Meeting Coverage:

American Academy of Ophthalmology

AAO: 2019

Iris Pigmented Tumors: When to Worry

Show Description +

Carol L. Shields, MD, surveys six types of iris pigmented tumors, focusing on the two most dangerous iris pigmented tumors, melanocytosis and melanoma. Dr. Shields details the risk profile of iris melanocytosis and explains how retina specialists can evaluate the risk of metastasis of iris melanoma.

Posted: 9/13/2019

Up Next


PANORAMA Study Data

Rishi P. Singh, MD

Gene Therapy for Wet AMD

Szilard Kiss, MD

ABC to Block VEGF-A Isoforms

Charles C. Wykoff, MD, PhD

Surgery for Viral Retinitis

J. Fernando Arevalo, MD, PhD, FACS

Iridocorneal Endothelial Syndrome

Lauren S. Blieden, MD

Advanced Diagnostics in Refractive Surgery: Epithelial Mapping and Phakic IOL Sizing

Dan Z. Reinstein, MD, MA(Cantab), FRCSC, DABO, FRCOphth, FEBO

Efficacy of Presbyond for the Correction of Presbyopia

Dan Z. Reinstein, MD, MA(Cantab), FRCSC, DABO, FRCOphth, FEBO

Autonomous AI in Ophthalmology

Michael D. Abramoff, MD, PhD

CXL for Infectious Keratitis

Farhad Hafezi, MD, PhD, FARVO

MIGS and Medications

Alex Huang, MD

Controlling Wound Healing Following PRK

Farhad Hafezi, MD, PhD, FARVO

A New Anti-VEGF Option

J. Fernando Arevalo, MD, PhD, FACS

Iris Pigmented Tumors: When to Worry

Carol L. Shields, MD, surveys six types of iris pigmented tumors, focusing on the two most dangerous iris pigmented tumors, melanocytosis and melanoma. Dr. Shields details the risk profile of iris melanocytosis and explains how retina specialists can evaluate the risk of metastasis of iris melanoma.

Posted: 9/13/2019


Please log in to leave a comment.

More From AAO: 2019 Coverage

A New Anti-VEGF Option

J. Fernando Arevalo, MD, PhD, FACS

PANORAMA Study Data

Rishi P. Singh, MD